ACTIVE_NOT_RECRUITING

Metabolic Health Improvement Program: Effects of a Workplace Sugary Beverages Sales Ban and Motivational Counseling

Talk to us

Conditions

Obesity, AbdominalInsulin Sensitivity

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the study is to test the impact of a multilevel workplace intervention (hospital-wide sales ban on sugar-sweetened beverages (SSBs) and individual-level brief counseling) on employee health.

Official Title

Multi-Level Trial of a Workplace Sales Ban of Sugary Beverages and Brief Motivational Counseling Intervention on Adiposity

Quick Facts

Study Start:2023-08-01
Study Completion:2026-10-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT05972109

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Full-time employee who works on campus at one of the Sutter Health participating sites
  2. * Speaks and reads English
  3. * Consumes three or more sugar-sweetened beverages (SSB) a week
  4. * Agrees to participate in two fasting blood draws
  1. * Pregnant

Contacts and Locations

Principal Investigator

Laura A Schmidt, Ph.D
PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Elissa Epel, Ph.D
PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Jamey Schmidt
PRINCIPAL_INVESTIGATOR
Sutter Health/California Pacific Medical Center Research Institute

Study Locations (Sites)

Sutter Health/California Pacific Medical Center Research Institute
San Francisco, California, 94115
United States

Collaborators and Investigators

Sponsor: University of California, San Francisco

  • Laura A Schmidt, Ph.D, PRINCIPAL_INVESTIGATOR, University of California, San Francisco
  • Elissa Epel, Ph.D, PRINCIPAL_INVESTIGATOR, University of California, San Francisco
  • Jamey Schmidt, PRINCIPAL_INVESTIGATOR, Sutter Health/California Pacific Medical Center Research Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-08-01
Study Completion Date2026-10-01

Study Record Updates

Study Start Date2023-08-01
Study Completion Date2026-10-01

Terms related to this study

Additional Relevant MeSH Terms

  • Obesity, Abdominal
  • Insulin Sensitivity